File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/978-981-15-3449-2_12
- Scopus: eid_2-s2.0-85085264802
- WOS: WOS:000703697400015
Supplementary
- Citations:
- Appears in Collections:
Book Chapter: Epigenetics in Multiple Sclerosis
Title | Epigenetics in Multiple Sclerosis |
---|---|
Authors | |
Keywords | DNA methylation Histone modification microRNAs Immunodysregulation Epigenetic therapeutics |
Issue Date | 2020 |
Publisher | Springer |
Citation | Epigenetics in Multiple Sclerosis. In Chang, C.& Lu, Q (Eds.), Epigenetics in Allergy and Autoimmunity, p. 309-374. Singapore: Springer, 2020 How to Cite? |
Abstract | Multiple sclerosis (MS) is an aggravating autoimmune disease that cripples young patients slowly with physical, sensory and cognitive deficits. The break of self-tolerance to neuronal antigens is the key to the pathogenesis of MS, with autoreactive T cells causing demyelination that subsequently leads to inflammation-mediated neurodegenerative events in the central nervous system. The exact etiology of MS remains elusive; however, the interplay of genetic and environmental factors contributes to disease development and progression. Given that genetic variation only accounts for a fraction of risk for MS, extrinsic risk factors including smoking, infection and lack of vitamin D or sunshine, which cause changes in gene expression, contribute to disease development through epigenetic regulation. To date, there is a growing body of scientific evidence to support the important roles of epigenetic processes in MS. In this chapter, the three main layers of epigenetic regulatory mechanisms, namely DNA methylation, histone modification and microRNA-mediated gene regulation, will be discussed, with a particular focus on the role of epigenetics on dysregulated immune responses and neurodegenerative events in MS. Also, the potential for epigenetic modifiers as biomarkers and therapeutics for MS will be reviewed. |
Persistent Identifier | http://hdl.handle.net/10722/294321 |
ISBN | |
ISI Accession Number ID | |
Series/Report no. | Advances in Experimental Medicine and Biology ; v. 1253 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, VSF | - |
dc.date.accessioned | 2020-11-23T08:29:42Z | - |
dc.date.available | 2020-11-23T08:29:42Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Epigenetics in Multiple Sclerosis. In Chang, C.& Lu, Q (Eds.), Epigenetics in Allergy and Autoimmunity, p. 309-374. Singapore: Springer, 2020 | - |
dc.identifier.isbn | 9789811534485 | - |
dc.identifier.uri | http://hdl.handle.net/10722/294321 | - |
dc.description.abstract | Multiple sclerosis (MS) is an aggravating autoimmune disease that cripples young patients slowly with physical, sensory and cognitive deficits. The break of self-tolerance to neuronal antigens is the key to the pathogenesis of MS, with autoreactive T cells causing demyelination that subsequently leads to inflammation-mediated neurodegenerative events in the central nervous system. The exact etiology of MS remains elusive; however, the interplay of genetic and environmental factors contributes to disease development and progression. Given that genetic variation only accounts for a fraction of risk for MS, extrinsic risk factors including smoking, infection and lack of vitamin D or sunshine, which cause changes in gene expression, contribute to disease development through epigenetic regulation. To date, there is a growing body of scientific evidence to support the important roles of epigenetic processes in MS. In this chapter, the three main layers of epigenetic regulatory mechanisms, namely DNA methylation, histone modification and microRNA-mediated gene regulation, will be discussed, with a particular focus on the role of epigenetics on dysregulated immune responses and neurodegenerative events in MS. Also, the potential for epigenetic modifiers as biomarkers and therapeutics for MS will be reviewed. | - |
dc.language | eng | - |
dc.publisher | Springer | - |
dc.relation.ispartof | Epigenetics in Allergy and Autoimmunity | - |
dc.relation.ispartofseries | Advances in Experimental Medicine and Biology ; v. 1253 | - |
dc.subject | DNA methylation | - |
dc.subject | Histone modification | - |
dc.subject | microRNAs | - |
dc.subject | Immunodysregulation | - |
dc.subject | Epigenetic therapeutics | - |
dc.title | Epigenetics in Multiple Sclerosis | - |
dc.type | Book_Chapter | - |
dc.identifier.email | Chan, VSF: sfvchan@hku.hk | - |
dc.identifier.authority | Chan, VSF=rp01459 | - |
dc.identifier.doi | 10.1007/978-981-15-3449-2_12 | - |
dc.identifier.scopus | eid_2-s2.0-85085264802 | - |
dc.identifier.hkuros | 319005 | - |
dc.identifier.volume | 1253 | - |
dc.identifier.spage | 309 | - |
dc.identifier.epage | 374 | - |
dc.identifier.isi | WOS:000703697400015 | - |
dc.publisher.place | Singapore | - |